Cargando…

Oncology patients’ experiences in experimental medicine cancer trials: a qualitative study

OBJECTIVES: The study aimed to explore patients’ experiences of experimental cancer medicine (ECM) clinical trials. DESIGN: The study’s design was qualitative. Two focus groups with patients were undertaken followed by semistructured interviews, to explore patients’ experiences of ECM clinical trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawyer, Chelsea, Preston, Laurie, Taylor, Sally, Davies, Michelle, Carter, Louise, Krebs, Matthew, Cook, Natalie, Graham, Donna, Thistlethwaite, Fiona, Yorke, Janelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493921/
https://www.ncbi.nlm.nih.gov/pubmed/34610932
http://dx.doi.org/10.1136/bmjopen-2020-047813
_version_ 1784579212404850688
author Sawyer, Chelsea
Preston, Laurie
Taylor, Sally
Davies, Michelle
Carter, Louise
Krebs, Matthew
Cook, Natalie
Graham, Donna
Thistlethwaite, Fiona
Yorke, Janelle
author_facet Sawyer, Chelsea
Preston, Laurie
Taylor, Sally
Davies, Michelle
Carter, Louise
Krebs, Matthew
Cook, Natalie
Graham, Donna
Thistlethwaite, Fiona
Yorke, Janelle
author_sort Sawyer, Chelsea
collection PubMed
description OBJECTIVES: The study aimed to explore patients’ experiences of experimental cancer medicine (ECM) clinical trials. DESIGN: The study’s design was qualitative. Two focus groups with patients were undertaken followed by semistructured interviews, to explore patients’ experiences of ECM clinical trials. Interviews and focus groups were audiorecorded and transcribed verbatim. Data were analysed using thematic analysis. SETTING: A regional cancer centre (tertiary care) in North-West England. PARTICIPANTS: Twelve patients (aged 52–79) participated in one of the two focus groups and 22 patients (aged 42–83) participated in interviews. PRIMARY OUTCOME MEASURE: Patients’ experiences of an ECM trial. RESULTS: Four main themes were identified from the analysis: decision making, information needs, the experience of trial participation and impact of trial participation. Subthemes are presented in the manuscript. CONCLUSION: To make fully informed decisions about trial participation, patients required the simplification of trial information and wanted more information about side effects, their response to trial treatment and the overall trial progress throughout the trial. Patients highlighted the need for improvement for the support provided to their family and friends.
format Online
Article
Text
id pubmed-8493921
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-84939212021-10-14 Oncology patients’ experiences in experimental medicine cancer trials: a qualitative study Sawyer, Chelsea Preston, Laurie Taylor, Sally Davies, Michelle Carter, Louise Krebs, Matthew Cook, Natalie Graham, Donna Thistlethwaite, Fiona Yorke, Janelle BMJ Open Oncology OBJECTIVES: The study aimed to explore patients’ experiences of experimental cancer medicine (ECM) clinical trials. DESIGN: The study’s design was qualitative. Two focus groups with patients were undertaken followed by semistructured interviews, to explore patients’ experiences of ECM clinical trials. Interviews and focus groups were audiorecorded and transcribed verbatim. Data were analysed using thematic analysis. SETTING: A regional cancer centre (tertiary care) in North-West England. PARTICIPANTS: Twelve patients (aged 52–79) participated in one of the two focus groups and 22 patients (aged 42–83) participated in interviews. PRIMARY OUTCOME MEASURE: Patients’ experiences of an ECM trial. RESULTS: Four main themes were identified from the analysis: decision making, information needs, the experience of trial participation and impact of trial participation. Subthemes are presented in the manuscript. CONCLUSION: To make fully informed decisions about trial participation, patients required the simplification of trial information and wanted more information about side effects, their response to trial treatment and the overall trial progress throughout the trial. Patients highlighted the need for improvement for the support provided to their family and friends. BMJ Publishing Group 2021-10-04 /pmc/articles/PMC8493921/ /pubmed/34610932 http://dx.doi.org/10.1136/bmjopen-2020-047813 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Oncology
Sawyer, Chelsea
Preston, Laurie
Taylor, Sally
Davies, Michelle
Carter, Louise
Krebs, Matthew
Cook, Natalie
Graham, Donna
Thistlethwaite, Fiona
Yorke, Janelle
Oncology patients’ experiences in experimental medicine cancer trials: a qualitative study
title Oncology patients’ experiences in experimental medicine cancer trials: a qualitative study
title_full Oncology patients’ experiences in experimental medicine cancer trials: a qualitative study
title_fullStr Oncology patients’ experiences in experimental medicine cancer trials: a qualitative study
title_full_unstemmed Oncology patients’ experiences in experimental medicine cancer trials: a qualitative study
title_short Oncology patients’ experiences in experimental medicine cancer trials: a qualitative study
title_sort oncology patients’ experiences in experimental medicine cancer trials: a qualitative study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493921/
https://www.ncbi.nlm.nih.gov/pubmed/34610932
http://dx.doi.org/10.1136/bmjopen-2020-047813
work_keys_str_mv AT sawyerchelsea oncologypatientsexperiencesinexperimentalmedicinecancertrialsaqualitativestudy
AT prestonlaurie oncologypatientsexperiencesinexperimentalmedicinecancertrialsaqualitativestudy
AT taylorsally oncologypatientsexperiencesinexperimentalmedicinecancertrialsaqualitativestudy
AT daviesmichelle oncologypatientsexperiencesinexperimentalmedicinecancertrialsaqualitativestudy
AT carterlouise oncologypatientsexperiencesinexperimentalmedicinecancertrialsaqualitativestudy
AT krebsmatthew oncologypatientsexperiencesinexperimentalmedicinecancertrialsaqualitativestudy
AT cooknatalie oncologypatientsexperiencesinexperimentalmedicinecancertrialsaqualitativestudy
AT grahamdonna oncologypatientsexperiencesinexperimentalmedicinecancertrialsaqualitativestudy
AT thistlethwaitefiona oncologypatientsexperiencesinexperimentalmedicinecancertrialsaqualitativestudy
AT yorkejanelle oncologypatientsexperiencesinexperimentalmedicinecancertrialsaqualitativestudy